SalaryGuide
AboutPricingFor Employers

Marketing jobs

5 marketing jobs

EMD Serono, Inc. logo
9 days ago

Global Marketing Director, OGSIVEO

EMD Serono, Inc.

Boston, MA (Hybrid)Full time$187K/yr – $280K/yr
EMD Serono, Inc. logo
5 weeks ago

Director, Regulatory Advertising and Promotion

EMD Serono, Inc.

Boston, MA (Hybrid)Full time$211K/yr – $316K/yr
EMD Serono, Inc. logo
6 weeks ago

Senior Product Manager, US TEPMETKO Marketing (Seaport MA)

EMD Serono, Inc.

Boston, MA (On-site)Full time$120K/yr – $180K/yr
EMD Serono, Inc. logo
3 months ago

Associate Director, Go-To-Market and Field Strategy, Fertility and Value & Access

EMD Serono, Inc.

Boston, MA (Hybrid)Full time$128K/yr – $191K/yr
EMD Serono, Inc. logo
3 months ago

Associate Director, US Value and Access Payer Marketing (on-site Seaport MA)

EMD Serono, Inc.

Boston, MA (On-site)Full time$164K/yr – $246K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

5 jobs
EMD Serono, Inc. logo

Global Marketing Director, OGSIVEO

EMD Serono, Inc.

Boston, MA (Hybrid)

$187K/yr - $280K/yrIn-houseFull-timeDirector/executive7+ years exp.
9 days ago
EMD Serono, Inc. logo

Director, Regulatory Advertising and Promotion

EMD Serono, Inc.

Boston, MA (Hybrid)

$211K/yr - $316K/yrIn-houseFull-timeDirector/executive8+ years exp.
5 weeks ago
EMD Serono, Inc. logo

Senior Product Manager, US TEPMETKO Marketing (Seaport MA)

EMD Serono, Inc.

Boston, MA (On-site)

$120K/yr - $180K/yrIn-houseFull-timeSenior level5+ years exp.
6 weeks ago
EMD Serono, Inc. logo

Associate Director, Go-To-Market and Field Strategy, Fertility and Value & Access

EMD Serono, Inc.

Boston, MA (Hybrid)

$128K/yr - $191K/yrIn-houseFull-timeSenior level6+ years exp.
3 months ago
EMD Serono, Inc. logo

Associate Director, US Value and Access Payer Marketing (on-site Seaport MA)

EMD Serono, Inc.

Boston, MA (On-site)

$164K/yr - $246K/yrIn-houseFull-timeSenior level5+ years exp.
3 months ago
EMD Serono, Inc. logo
EMD Serono, Inc.

Global Marketing Director, OGSIVEO

Boston, MA (Hybrid)

$187K/yr – $280K/yrDirector/Executive7+ years expFull time

Posted 9 days ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own global brand strategy execution and cross-functional leadership to translate strategy into local tools, guide congress initiatives, and drive market shaping through collaborative partnerships.

  • Translate strategy into local toolkits and collateral
  • Lead congress strategy and cross-functional collaboration
  • Manage multiple projects and ensure timely, compliant delivery

Job Description

Responsibilities

  • Support Global Brand Lead to develop brand strategy incl. positioning, messaging, digital frameworks
  • Translate global brand strategy into actionable toolkits (e.g., messaging guides, launch checklists, best practices, etc.) for local teams, particularly ex-US
  • Ensure sufficient knowledge transfer and brand strategy dissemination with local teams, while also ensuring on-the-ground perspectives are incorporated into global strategy
  • Oversee global congress strategy and execution; guide local congress strategy
  • Develop a deep understanding of disease state, market dynamics, unmet needs, and brand/competitive data to lead the development and evolution of market shaping and brand building initiatives.
  • Provide strategic input to the Global Brand Team
  • Demonstrate and develop strong relationships with key external and internal stakeholders.
  • Collaborate with cross-functional partners in Marketing, Sales, Market Access, Medical Affairs, and others as required and appropriate to define and execute tactical plans.
  • Ability to independently and proactively identify strategic opportunities, build plans and execute against them
  • Attend and/or participate at conventions, conferences, and tradeshows, preparing engaging displays and collateral as needed, and provide post-event reports and analysis

Requirements

  • Bachelor's degree (business or related disciplines). MBA or other advanced degree preferred.
  • 7+ years of relevant pharmaceutical and/or biotechnology commercial experience

Preferred

  • S. launch and in-line marketing experience; sales experience is a preferred
  • Oncology and rare disease experience preferred
  • Microsoft Office
  • Brand planning
  • Launch and tactical planning
  • Strong track record of influencing key stakeholders and leadership with and without authority
  • Clear communicator able to engage, influence and navigate cross-functional stakeholders
  • Team player and strong track record of collaboration
  • Strong sense of urgency and ability to organize, prioritize, activate and execute
  • Strong interpersonal communication skills to collaborate with colleagues, stakeholders, and vendors effectively and clearly in a remote hybrid work environment.

Benefits

  • benefits offered by the Company include health insurance, paid time off (PTO), retirement contributions, and other perquisites.
EMD Serono, Inc. logo

EMD Serono, Inc.

We aspire to create, improve and prolong life for people living with difficult-to-treat conditions like infertility, multiple sclerosis and cancer. We are imagining the future of healthcare by working to translate the discovery of molecules into potentially meaningful outcomes for people with serious unmet medical needs. EMD Serono is the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada. Our global roots go back more than 350 years. Today, we have approximately 1,100 employees around the US with commercial, clinical and research operations in Massachusetts.Community Guidelines: https://bit.ly/2nbPYl1

Founded in 1981
Boston, Massachusetts, USA
1.8K employees (107 in marketing)
www.emdserono.com

Traffic Signals

Monthly Visitors
24.3K
Traffic Source Mix
Search
46.2%
Direct
38.4%
Referral
8.9%
Social
4.9%
Paid
1.4%

Headcount Trend

Current headcount: ~1.8K

Marketing Team

Marketing Team Size
100 (5% of company)
Median Career Experience
20 years
Median Tenure
8 years
Marketing Roles Posted (Last 30 Days)
2

People

HR / Recruitment

Katherine Nicolosi
Katherine Nicolosi
Senior Talent Acquisition Advisor
At the company for 10 years 10 months
Sarah Turner
Sarah Turner
Global Head HR Business Partners, Healthcare Marketing & North America
At the company for 8 years 3 months

Marketing Leadership

Josh Reed
Josh Reed
Chief of Staff, Office of the Chief Marketing Officer
At the company for 12 years 3 months
Michelle Westhaver
Michelle Westhaver
Executive Assistant to Chief Marketing Officer
At the company for 8 years 6 months
Nader Khedr
Nader Khedr
Vice President Head of US Fertility Marketing
At the company for 8 years 4 months
Dustin P.
Dustin P.
Vice President, Head of US Value and Access Strategic Marketing
At the company for 5 years 4 months

Recent News

EMD Serono Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia Gravis
Nov 24, 2025 • Yahoo Finance
Trump announces lower prices for fertility medications
Oct 21, 2025 • The American Bazaar
Trump Announces Lower-Cost Fertility Drug Deal With EMD Serono
Oct 20, 2025 • El Paso Inc.
In Affordability Push, EMD Serono Joins TrumpRx While Roche Launches DTC Program
Oct 17, 2025 • NewsBreak: Local News & Alerts
EMD Serono partners US government to widen IVF access
Oct 17, 2025 • Yahoo
EMD Serono, CVS Health To Partner On TrumpRx Fertility Program Launching In 2026
Oct 17, 2025 • Benzinga
EMD Serono, CVS Health To Partner On TrumpRx Fertility Program Launching In 2026
Oct 16, 2025 • Sahm
EMD Serono announces agreement with U.S. government to expand access to IVF therapies
Oct 16, 2025 • MarketScreener
EMD Serono Announces Unprecedented Agreement with U.S. Government to Expand Access to IVF Therapies
Oct 16, 2025 • Business Wire
EMD Serono to offer discounted fertility treatments in TrumpRx IVF program
Oct 16, 2025 • Seeking Alpha
EMD Serono to Present New Data Highlighting Durable Effects of MAVENCLAD
Sep 17, 2025 • Business Wire
NORD's 2025 Rare Diseases & Orphan Products Breakthrough Summit to Spotlight CEOs, Investors, and Regulatory Leaders Driving Innovation
Aug 21, 2025 • Morningstar.com
Thousands Nationwide to Walk in Honor of Ovarian Cancer Awareness Month
Aug 12, 2025 • EIN Presswire
Donald Trump's crackdown at pharma: 'Americans need lower drug prices'; sets 29 September deadline or face action
Aug 1, 2025 • IndiaTimes
Trump urges top drugmakers to cut U.S. prescription drug costs
Aug 1, 2025 • TechTarget
Trump back on the attack against the pharmaceutical industry
Aug 1, 2025 • MarketScreener
Trump gives pharma ultimatum on most favoured nation pricing
Jul 31, 2025 • pharmaphorum
Trump demands pharma CEOs lower drug prices within 60 days
Jul 31, 2025 • Investing.com
White House threatens to 'deploy every tool in our arsenal' to implement most-favored-nation drug pricing
Jul 31, 2025 • FiercePharma
Poly ADP-Ribose Polymerase PARP Inhibitors Report 2025 – For Strategy Officers And Market Intelligence Teams
Jul 24, 2025 • EIN Presswire
CEO Roundtable on Cancer Appoints Two Esteemed Oncology Leaders to Life Sciences Council
Jul 7, 2025 • EIN Presswire
EMD Serono Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025
Jun 13, 2025 • BioSpace
EMD Serono Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025
Jun 12, 2025 • Yahoo Finance
In the clinic for May 29, 2025
May 29, 2025 • BioWorld Financial Watch
EMD Serono Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025
May 23, 2025 • BioSpace
EMD Serono Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025
May 22, 2025 • Business Wire
EMD Serono Presents Positive Phase 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in Patients with Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) with Active Lupus Rash
May 21, 2025 • Business Wire
Longwood Healthcare Leaders to Convene Top Life Science E...
May 15, 2025 • PharmiWeb
Bank to consolidate HQ into former EMD Serono office
May 1, 2025 • Seattle TechFlash
Fernández Alcalde takes the reins at EMD Serono, one of Boston’s newest biotechs
Mar 24, 2025 • BostonGlobe.com
EMD Serono’s new president is on the hunt for deals in Boston
Mar 21, 2025 • The Business Journals
Immuno Oncology Market Anticipated to Reach USD 305.35 Billion, at a Notable 9.28% CAGR by 2034
Mar 18, 2025 • EIN Presswire
Rebif Market Forecast 2025-2034: Comprehensive Insights On Market Size, Growth Factors, Trends, Competitive Landscape
Mar 12, 2025 • EIN Presswire
Selma Blair collabs with EMD Serono for DTC campaign about relapsing MS
Mar 10, 2025 • Medical Marketing and Media
BAVENCIO Continues to Strengthen Its Position in the Immuno-Oncology Landscape | DelveInsight
Mar 10, 2025 • prnewswire.co.uk
BAVENCIO Continues to Strengthen Its Position in the Immuno-Oncology Landscape | DelveInsight
Mar 10, 2025 • PR Newswire
TEPMETKO Continues to Strengthens its Position as a Leading METex14 Skipping NSCLC Therapy | DelveInsight
Mar 6, 2025 • PR Newswire
TEPMETKO Continues to Strengthens its Position as a Leading METex14 Skipping NSCLC Therapy | DelveInsight
Mar 6, 2025 • prnewswire.co.uk
EMD Serono and SiS launch corporate accelerator programme for women's health innovators
Mar 5, 2025 • FemTech World
Antonio Gualberto: I’m starting a new position as Global Head, Due Diligence Oncology at EMD Serono
Jan 16, 2025 • Oncodaily
Five things: Hotel unions, hospital costs, Newbury St. shopping, and life after iRobot
Dec 13, 2024 • Boston Business Journal
Petri Dish: EMD Serono’s new president; Prostate cancer drug success
Dec 12, 2024 • Boston Business Journal
Appointments and advancements for Dec. 11, 2024
Dec 11, 2024 • BioWorld Financial Watch
EMD Serono Appoints Miguel Fernández Alcalde to Lead North American Healthcare Business
Dec 10, 2024 • Business Wire
EMD Serono Appoints Miguel Fernández Alcalde to Lead North American Healthcare Business
Dec 10, 2024 • citybiz
EMD Serono Appoints Miguel Fernández Alcalde to Lead North American Healthcare Business
Dec 10, 2024 • Business Wire
CORRECTED: Takeda to cut another 220 jobs in Massachusetts, as Merck KGaA plots office move
Jul 2, 2024 • FiercePharma
EMD Serono to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
May 23, 2024 • Yahoo Finance
Merck KGaA earmarks €300M for an advanced research center at its HQ site
Apr 29, 2024 • Fierce Pharma
EMD Serono Presents New MAVENCLAD® Data Supporting Cognitive Function Benefits
Mar 6, 2024 • Business Wire
FDA grants traditional approval for Merck's Tepmetko
Mar 6, 2024 • The Pharma Letter
EMD Serono Presents New MAVENCLAD® Data Supporting Cognitive Function Benefits
Feb 29, 2024 • Morningstar
Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in ...
Jan 22, 2024 • Yahoo Finance
EMD Serono lays out MS therapies' immune-system suppression risks in new campaign
Jan 17, 2024 • Endpoints News
Gilde Healthcare's €140M; EMD Serono to move US HQ to Boston; Arcturus up for $35M milestone
Nov 15, 2023 • Endpoints News
EMD Serono to move HQ to Seaport from the suburbs
Nov 14, 2023 • Boston Business Journal
EMD Serono headquarters plans to join biopharma cluster in Boston’s Seaport
Jan 1, 1970 • Bost.com
EMD Serono Announces Plans for New U.S. Healthcare Headquarters in Boston's Seaport District
Jan 1, 1970